Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

407-41-0

Phosphoserine-L-O

407-41-0
81131-70-6

Pravastatin sodium

81131-70-6
318-98-9

Propanolol HCl

318-98-9
57-83-0

Progesterone

57-83-0
125-33-7

Primidone

125-33-7
102625-70-7

Pantoprazole

102625-70-7
90-82-4

Pseudoephedrine

90-82-4
66093-90-1

Pseudooxynicotine

66093-90-1
1263-89-4

Paromomycine sulfate

1263-89-4
53910-25-1

Pentostatine

53910-25-1
366-70-1

Procarbazine HCl

366-70-1
148553-51-9

Pregabalin impurete V

148553-51-9
148553-50-8

Pregabalin

148553-50-8
134-04-3

Pelargonidin chloride

134-04-3
2955-38-6

Prazepam

2955-38-6
06/05/6493

Pentoxifylline

06/05/6493
57186-25-1

Paxillin

57186-25-1
19562-30-2

Piromidic Acid

19562-30-2
58-33-3

Promethazine HCl

58-33-3
7681-67-6

Propionylpromazine HCl

7681-67-6